As a pioneer in the field of Regenerative Medicine, Organogenesis is proud to be on the forefront of making this technology into a reality for patients today.
A new era in medicine arrived when Organogenesis received one of the first FDA approvals for a living, human cell-based product. Apligraf® is now the leading regenerative medicine brand in the world.
Additionally, we are actively developing new breakthroughs. For instance, the company recently earned FDA approval for our latest breakthrough, GINTUIT™ for oral soft tissue regeneration.
Click through for more information about the science of Regenerative Medicine at Organogenesis.
ليست هناك تعليقات:
إرسال تعليق